GoHealth (NASDAQ:GOCO) Announces Earnings Results

GoHealth (NASDAQ:GOCO) issued its quarterly earnings results on Tuesday. The company reported ($1.03) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.69) by $1.66, FiscalAI reports. GoHealth had a positive return on equity of 8.00% and a negative net margin of 26.95%.The firm had revenue of $12.64 million during the quarter, compared to the consensus estimate of $88.62 million.

GoHealth Stock Down 11.9%

Shares of NASDAQ GOCO opened at $1.33 on Thursday. The firm has a market cap of $38.19 million, a PE ratio of -0.07 and a beta of 1.70. The company’s fifty day simple moving average is $1.77 and its 200 day simple moving average is $2.83. GoHealth has a 12-month low of $1.30 and a 12-month high of $12.37.

Hedge Funds Weigh In On GoHealth

Institutional investors have recently made changes to their positions in the stock. Goldman Sachs Group Inc. bought a new position in shares of GoHealth during the 4th quarter worth about $26,000. Charles Schwab Investment Management Inc. increased its position in GoHealth by 119.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 26,448 shares of the company’s stock valued at $57,000 after buying an additional 14,388 shares in the last quarter. American Century Companies Inc. bought a new stake in GoHealth in the 2nd quarter valued at about $63,000. Franklin Resources Inc. acquired a new position in GoHealth during the 3rd quarter worth approximately $66,000. Finally, Deutsche Bank AG raised its stake in GoHealth by 150.8% during the 4th quarter. Deutsche Bank AG now owns 32,183 shares of the company’s stock worth $69,000 after buying an additional 19,349 shares during the period. Institutional investors and hedge funds own 24.21% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. Weiss Ratings reissued a “sell (e+)” rating on shares of GoHealth in a research note on Monday, December 29th. Noble Financial upgraded GoHealth to a “strong-buy” rating in a report on Wednesday. One analyst has rated the stock with a Strong Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, GoHealth currently has a consensus rating of “Hold” and a consensus target price of $5.00.

About GoHealth

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.